Education
About Us
Working with TipRanks
Follow Us
Femasys, Inc. (FEMY)
:FEMY
FEMY Stock Chart & Stats
$0.90
-$0.01(-0.91%)
At close: 4:00 PM EST
$0.90
-$0.01(-0.91%)
Day’s Range― - ―
52-Week Range$0.31 - $1.80
Previous CloseN/A
Volume25.00K
Average Volume (3M)11.52M
Market Cap
$53.80M
Enterprise Value$18.31M
Total Cash (Recent Filing)$4.57M
Total Debt (Recent Filing)$8.43M
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Mar 26, 2026EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding58,479,824
10 Day Avg. Volume5,721,740
30 Day Avg. Volume11,520,103
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)10.63
Price to Sales (P/S)15.04
P/FCF Ratio-1.21
Enterprise Value/Market Cap0.34
Enterprise Value/Revenue8.88
Enterprise Value/Gross Profit20.96
Enterprise Value/Ebitda-1.08
Forecast
1Y Price Target
$5.83Price Target Upside547.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.55
Revenue Forecast (FY)$3.62M
Bulls Say, Bears Say
Bulls Say
Regulatory ApprovalsFemasys continues to advance the global expansion of its permanent birth control product, FemBloc, securing regulatory approvals in the UK.
Revenue GrowthFemasys reported results with $0.7M in revenue primarily from sales of FemBloc and commercial products, up 78%.
Strategic PartnershipFemasys has secured a significant strategic partnership with Kebomed to commercialize its FemBloc across France and the Benelux region, marking a major step in its European growth strategy.
Bears Say
Femasys News
FEMY FAQ
What was Femasys, Inc.’s price range in the past 12 months?
Femasys, Inc. lowest stock price was $0.31 and its highest was $1.80 in the past 12 months.
What is Femasys, Inc.’s market cap?
Femasys, Inc.’s market cap is $53.80M.
When is Femasys, Inc.’s upcoming earnings report date?
Femasys, Inc.’s upcoming earnings report date is Mar 26, 2026 which is in 112 days.
How were Femasys, Inc.’s earnings last quarter?
Femasys, Inc. released its earnings results on Nov 14, 2025. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.115 by $0.015.
Is Femasys, Inc. overvalued?
According to Wall Street analysts Femasys, Inc.’s price is currently Undervalued.
Does Femasys, Inc. pay dividends?
Femasys, Inc. does not currently pay dividends.
What is Femasys, Inc.’s EPS estimate?
Femasys, Inc.’s EPS estimate is -0.09.
How many shares outstanding does Femasys, Inc. have?
Femasys, Inc. has 58,479,824 shares outstanding.
What happened to Femasys, Inc.’s price movement after its last earnings report?
Femasys, Inc. reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.115. Following the earnings report the stock price went up 8.434%.
Which hedge fund is a major shareholder of Femasys, Inc.?
Currently, no hedge funds are holding shares in FEMY
Femasys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.83 (547.78% Upside)
$5.83 (547.78% Upside)
Blogger Sentiment
Bullish
FEMY Sentiment 70%
Sector Average 68%
Sector Average 68%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 14.7%
Last 30 Days ▲ 14.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.91%
12-Months-Change
Fundamentals
Return on Equity
-376.23%
Trailing 12-Months
Asset Growth
4.52%
Trailing 12-Months
Company Description
Femasys, Inc.
Femasys (FEMY) is a biotechnology company focused on advancing women's health by developing innovative medical devices and solutions for reproductive health. The company operates primarily in the healthcare sector, specializing in products that address various aspects of female fertility and contraception. Femasys's core offerings include its proprietary systems for non-surgical treatment options, which aim to improve accessibility and effectiveness for women seeking reproductive health solutions.
FEMY Stock 12 Month Forecast
Average Price Target
$5.83
▲(547.78% Upside)
Technical Analysis
Retractable Technologies
―
Milestone Scientific
―
Precision Optics Corporation
―
NexGel Inc
―
Meihua International Medical Technologies Co., Ltd.
―
Ownership Overview
4.23% Insiders
2.72% Mutual Funds
5.17% Other Institutional Investors
85.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---